Fluralaner, isoxazoline class compound, is a systemic insecticide and acaricide with antiparasitic activity against cat and dog fleas and ticks. Fluralaner is an inhibitor of the arthropod nervous system. Fluralaner inhibits γ-aminobutyric acid (GABA)-gated chloride channels (GABACls) and L-glutamate-gated chloride channels (GluCls). Potency of fluralaner is comparable to fipronil (a phenylpyrazole ectoparasiticide). Fluralaner API in this report.
The global market for Fluralaner API is estimated to increase from US$ 66 million in 2021 to reach US$ 90 million by 2028, exhibiting a CAGR of 4.7% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Global key manufacturers of Fluralaner API include Nissan Chemical, Hikal, Hubei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu, etc. Global top five manufacturers hold a share about 85%. Asia-Pacific is the largest market of Fluralaner API, holds a share over 35%. In terms of product, purity above 98% ones hold a larger segment, with a share over 75%. And in terms of application, the largest application is oral drug, with a share of over 70%.
This latest report provides a deep insight into the global Fluralaner API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Fluralaner API market, with both quantitative and qualitative data, to help readers understand how the Fluralaner API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.
The study segments the Fluralaner API market and forecasts the market size by Type (Purity above 98% and Purity below 98%,), by Application (Oral Drug and Topical Drug.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Purity above 98%
Purity below 98%
Segmentation by application
Segmentation by region
Middle East & Africa
Major companies covered
Hubei Masteam Bio-tech
Zhejiang Gihi Chemicals
Hunan Huateng Pharmaceutical
Taizhou Crene Biotechnology
Chapter 1: Scope of Fluralaner API, Research Methodology, etc.
Chapter 2: Executive Summary, global Fluralaner API market size (sales and revenue) and CAGR, Fluralaner API market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Fluralaner API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Fluralaner API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Fluralaner API market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Nissan Chemical, Hikal, Hubei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu, Zhejiang Gihi Chemicals, Hunan Huateng Pharmaceutical and Taizhou Crene Biotechnology, etc.
Chapter 14: Research Findings and Conclusion